The "Green Bioprocessing" Mandate: How 2026 is Cleaning Up the Vaccine Supply Chain.
In late 2026, the industry is pivoting toward "Zero-Waste Biomanufacturing." This year, a radical new class of biodegradable single-use bioreactors is being tested to reduce the environmental footprint of vaccine production. This innovation is a primary driver for the market, as major pharmaceutical sponsors now include "Sustainability Metrics" in their contract renewals. Using these...
0 Comments 0 Shares 35 Views 0 Reviews
MakeMyFriends https://makemyfriends.com